Dapsone resistance does not appear to be associated with a mutation in the dihydropteroate synthase-2 gene of Mycobacterium leprae

Indian Journal of Leprosy

Volumn 71, Issue 1, 1999, Pages 11-18

  Gillis, T P ^a   Williams, D L ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAPSONE; DIHYDROPTEROATE SYNTHASE;

ANTIBIOTIC RESISTANCE; BACTERIAL GENE; CONFERENCE PAPER; DNA FLANKING REGION; DNA HYBRIDIZATION; DNA SEQUENCE; GENE AMPLIFICATION; GENE MUTATION; MYCOBACTERIUM LEPRAE; NONHUMAN; OPEN READING FRAME; RESTRICTION FRAGMENT;

AMINO ACID SEQUENCE; ANIMALS; DAPSONE; DIHYDROPTEROATE SYNTHASE; DNA, BACTERIAL; DRUG RESISTANCE, MICROBIAL; HUMANS; LEPROSTATIC AGENTS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; MUTATION; MYCOBACTERIUM LEPRAE;

EID: 0032775410     PISSN: 02549395     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (16)

1. Allegra CJ, Boarman D, Kovacs JA et al 1990. Interaction of sulfonamide and sulfone compounds with Toxoplasma gondii dihydropteroate synthase. J Clin Invest 85: 371-379.
2. Butlin CR, Neupane KD, Failbus SS et al 1996. Drug resistance in Nepali leprosy patients. Int J Lepr 64: 136-141.
3. Chen J, Wang S, Haw Y et al 1989. Primary dapsone resistance in China. Lepr Rev 60: 263-266.
4. Clark-Curtiss JE, Jacobs WR, Docherty MA et al 1985. Molecular analysis of DNA and construction of genomic libraries of M. leprae. J Bacteriol 161: 1093-1102.
5. Cole S, Brosch R, Parkhill J et al 1988. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393: 537-544.
6. De la Cruz E, Cellona RV, Balagon MVF et al 1996. Primary dapsone resistance in Cebu, The Philippines; cause for concern. Int J Lepr 64: 253-267.
7. Guinto RS, Cellona RV, Fajardo TT et al 1981. Primary dapsone-resistant leprosy in Cebu, Philippines. Int J Lepr 49: 427-430.
8. Ji B 1985. Drug resistance in leprosy - a review. Lepr Rev 56: 265-278.
9. Richey DP, Brown GM 1969. The biosynthesis of folic acid. IX. Purification and properties of the enzymes required for the formation of dihydropteroic acid. J Biol Chem 244: 1582-1592.
10. Seydel JK, Kulkarni VM 1983. Inhibitory activity and mode of action of DDS in cell -free folate synthesizing systems prepared from M. leprae and M. lufu. Chemotherapy 29: 58-67.
11. Seydel JK, Ritcher M, Wempe E 1980. Mechanism of action of the folate blocker diaminodiphenylsulfone (dapsone, DDS): studies in E. coli cell-free enzyme extracts in comparison to sulfonamides. Int J Lepr 48: 18-29.
12. Shepard CC 1982. Statistical analysis of results obtained by two methods of testing drug activity against M. leprae. Int J Lepr 50: 96-101.
13. Shepard CC, Rees RJ, Levy L et al 1986. Susceptibility of strains of Mycobacterium leprae isolated prior to 1977 from patients with previously untreated lepromatous leprosy. Int J Lepr 54: 11-15.
14. WHO 1994. Chemotherapy of leprosy. Report of a WHO Study Group. Tech Rep Ser 847.
15. Williams DL, Gillis TP 1988. A study of the relatedness of M. leprae isolates using RFLP analysis. Acta Leprologica 7: 226-230.
16. Williams DL, Gillis TP, Fiallo P et al 1992. Detection of M. leprae and the potential for monitoring antileprosy drug therapy directly from skin biopsies by PCR. Mol Cell Probes 6: 401-410.